These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 10755578)

  • 1. Open-label treatment with risperidone of 26 psychiatrically-hospitalized children and adolescents with mixed diagnoses and aggressive behavior.
    Buitelaar JK
    J Child Adolesc Psychopharmacol; 2000; 10(1):19-26. PubMed ID: 10755578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomized controlled trial of risperidone in the treatment of aggression in hospitalized adolescents with subaverage cognitive abilities.
    Buitelaar JK; van der Gaag RJ; Cohen-Kettenis P; Melman CT
    J Clin Psychiatry; 2001 Apr; 62(4):239-48. PubMed ID: 11379837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term safety and efficacy of risperidone for the treatment of disruptive behavior disorders in children with subaverage IQs.
    Turgay A; Binder C; Snyder R; Fisman S
    Pediatrics; 2002 Sep; 110(3):e34. PubMed ID: 12205284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risperidone for young children with mood disorders and aggressive behavior.
    Schreier HA
    J Child Adolesc Psychopharmacol; 1998; 8(1):49-59. PubMed ID: 9639079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Weight gain in a controlled study of risperidone in children, adolescents and adults with mental retardation and autism.
    Hellings JA; Zarcone JR; Crandall K; Wallace D; Schroeder SR
    J Child Adolesc Psychopharmacol; 2001; 11(3):229-38. PubMed ID: 11642473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risperidone and explosive aggressive autism.
    Horrigan JP; Barnhill LJ
    J Autism Dev Disord; 1997 Jun; 27(3):313-23. PubMed ID: 9229261
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A crossover study of risperidone in children, adolescents and adults with mental retardation.
    Hellings JA; Zarcone JR; Reese RM; Valdovinos MG; Marquis JG; Fleming KK; Schroeder SR
    J Autism Dev Disord; 2006 Apr; 36(3):401-11. PubMed ID: 16596465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A case series of eight aggressive young children treated with risperidone.
    Cesena M; Gonzalez-Heydrich J; Szigethy E; Kohlenberg TM; DeMaso DR
    J Child Adolesc Psychopharmacol; 2002; 12(4):337-45. PubMed ID: 12625994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Weight gain with risperidone among patients with mental retardation: effect of calorie restriction.
    Cohen S; Glazewski R; Khan S; Khan A
    J Clin Psychiatry; 2001 Feb; 62(2):114-6. PubMed ID: 11247096
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Olanzapine vs. risperidone in treating aggressive behaviours in adults with intellectual disability: a single blind study.
    Amore M; Bertelli M; Villani D; Tamborini S; Rossi M
    J Intellect Disabil Res; 2011 Feb; 55(2):210-8. PubMed ID: 21129058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness, safety, and tolerability of risperidone in adolescents with schizophrenia: an open-label study.
    Zalsman G; Carmon E; Martin A; Bensason D; Weizman A; Tyano S
    J Child Adolesc Psychopharmacol; 2003; 13(3):319-27. PubMed ID: 14642020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risperidone for aggression and self-injurious behavior in adults with mental retardation.
    Cohen SA; Ihrig K; Lott RS; Kerrick JM
    J Autism Dev Disord; 1998 Jun; 28(3):229-33. PubMed ID: 9656134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risperidone in the treatment of behavioral disturbances in children and adolescents with borderline intellectual functioning: a double-blind, placebo-controlled pilot trial.
    Van Bellinghen M; De Troch C
    J Child Adolesc Psychopharmacol; 2001; 11(1):5-13. PubMed ID: 11322745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treating disruptive behavior disorders with risperidone: a 1-year, open-label safety study in children and adolescents.
    Haas M; Karcher K; Pandina GJ
    J Child Adolesc Psychopharmacol; 2008 Aug; 18(4):337-45. PubMed ID: 18759643
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Double-blind, placebo-controlled study of risperidone for the treatment of disruptive behaviors in children with subaverage intelligence.
    Aman MG; De Smedt G; Derivan A; Lyons B; Findling RL;
    Am J Psychiatry; 2002 Aug; 159(8):1337-46. PubMed ID: 12153826
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Experience with Risperidone in the treatment of institutionalized mentally retarded patients, with special reference to treatment of aggressive states].
    Hal V; Fehér L
    Neuropsychopharmacol Hung; 2004 Mar; 6(1):19-25. PubMed ID: 15125310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risperidone for controlling aggressive behavior in a mentally retarded child: a case report.
    Maneeton N; Intaprasert S; Srisurapanont M
    J Med Assoc Thai; 2001 Jun; 84(6):893-6. PubMed ID: 11556472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Possibilities and limits of treatment of aggressive behavior in patients with mental retardation with risperidone].
    Hässler F; Buchmann J; Bohne S
    Nervenarzt; 2002 Mar; 73(3):278-82. PubMed ID: 11963264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of aggressive behavior problems in boys with intellectual disabilities using zuclopenthixol.
    Hässler F; Dück A; Jung M; Reis O
    J Child Adolesc Psychopharmacol; 2014 Dec; 24(10):579-81. PubMed ID: 25514543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risperidone in children and adolescents with pervasive developmental disorder: pilot trial and follow-up.
    Perry R; Pataki C; Munoz-Silva DM; Armenteros J; Silva RR
    J Child Adolesc Psychopharmacol; 1997; 7(3):167-79. PubMed ID: 9466234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.